Terms: = Endocrine gland cancer AND PDGFB, SIS, 5155, ENSG00000100311, FLJ12858, PDGF2, P01127, c-sis, SSV AND Prognosis
12 results:
1. An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer.
Wieser V; Tsibulak I; Reimer DU; Zeimet AG; Fiegl H; Hackl H; Marth C
Gynecol Oncol; 2023 Mar; 170():290-299. PubMed ID: 36758419
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic Impact of the Preoperative Systemic Inflammation Score in Patients With Pancreatic Ductal Adenocarcinoma.
Iguchi T; Iseda N; Hirose K; Itoh S; Harada N; Ninomiya M; Sugimachi K; Honboh T; Maeda T; Sadanaga N; Matsuura H
Am Surg; 2023 Jun; 89(6):2213-2219. PubMed ID: 35392670
[TBL] [Abstract] [Full Text] [Related]
3. Combined systemic inflammation score (sis) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy.
Markus M; Abendroth A; Noureddine R; Paul A; Breitenbuecher S; Virchow I; Schmid KW; Markus P; Schumacher B; Wiesweg M; Wendling J; Mende B; Siveke JT; Schuler M; Kasper S
J Cancer Res Clin Oncol; 2021 Feb; 147(2):579-591. PubMed ID: 32839836
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance and predictors of the system inflammation score in ovarian clear cell carcinoma.
Zhang H; Lu J; Lu Y; Zhou J; Wang Z; Liu H; Xu C
PLoS One; 2017; 12(5):e0177520. PubMed ID: 28498842
[TBL] [Abstract] [Full Text] [Related]
5. The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer.
Wilson C; Qiu L; Hong Y; Karnik T; Tadros G; Mau B; Ma T; Mu Y; New J; Louie RJ; Gunewardena S; Godwin AK; Tawfik OW; Chien J; Roby KF; Krieg AJ
Oncogene; 2017 May; 36(18):2565-2576. PubMed ID: 27869162
[TBL] [Abstract] [Full Text] [Related]
6. Coupling of LETM1 up-regulation with oxidative phosphorylation and platelet-derived growth factor receptor signaling via YAP1 transactivation.
Lee J; Lee WK; Seol MY; Lee SG; Kim D; Kim H; Park J; Jung SG; Chung WY; Lee EJ; Jo YS
Oncotarget; 2016 Oct; 7(41):66728-66739. PubMed ID: 27556512
[TBL] [Abstract] [Full Text] [Related]
7. [The correlation between BRAF mutations, RET/PTC rearrangements and platelet-derived growth factor B expression in papillary thyroid carcinomas].
Wang P; Wang YG; Zhao WJ; Fu YD; Wang L; Wang F; Zhao SH
Zhonghua Nei Ke Za Zhi; 2012 Dec; 51(12):987-91. PubMed ID: 23327964
[TBL] [Abstract] [Full Text] [Related]
8. PDGFRβ expression in tumor stroma of pancreatic adenocarcinoma as a reliable prognostic marker.
Yuzawa S; Kano MR; Einama T; Nishihara H
Med Oncol; 2012 Dec; 29(4):2824-30. PubMed ID: 22403002
[TBL] [Abstract] [Full Text] [Related]
9. Borderline tumors of the ovary: clinical course and prognostic factors.
Ewald-Riegler N; du Bois O; Fisseler-Eckhoff A; Kommoss F; Harter P; Traut A; Hils R; du Bois A
Onkologie; 2012; 35(1-2):28-33. PubMed ID: 22310342
[TBL] [Abstract] [Full Text] [Related]
10. Paneling human thyroid cancer cell lines for candidate proteins for targeted anti-angiogenic therapy.
Hoffmann S; Wunderlich A; Celik I; Maschuw K; Hassan I; Hofbauer LC; Zielke A
J Cell Biochem; 2006 Jul; 98(4):954-65. PubMed ID: 16475167
[TBL] [Abstract] [Full Text] [Related]
11. Expression and amplification of the HER-2/neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell lines.
Tyson FL; Boyer CM; Kaufman R; O'Briant K; Cram G; Crews JR; Soper JT; Daly L; Fowler WC; Haskill JS
Am J Obstet Gynecol; 1991 Sep; 165(3):640-6. PubMed ID: 1679963
[TBL] [Abstract] [Full Text] [Related]
12. Oncogene expression in endocrine pancreatic tumors.
Höfler H; Ruhri C; Pütz B; Wirnsberger G; Hauser H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 55(6):355-61. PubMed ID: 2904191
[TBL] [Abstract] [Full Text] [Related]